Androgen deprivation therapy for prostate cancer and its complications
A. Pope, Paul David Abel
Abstract
A. Pope, Paul David Abel
Abstract
Abstract This article focuses on the hormonal treatment of prostate cancer by the reduction of androgen activity. The authors outline the under‐recognised complications that can be caused by the castration effect of androgen deprivation therapy. Copyright © 2010 Wiley Interface Ltd
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract This article focuses on the hormonal treatment of prostate cancer by the reduction of androgen activity. The authors outline the under‐recognised complications that can be caused by the castration effect of androgen deprivation therapy. Copyright © 2010 Wiley Interface Ltd
Key concepts: Prostate cancer, Androgen deprivation therapy, Medicine, Androgen, Castration, Hormonal therapy, Oncology, Cancer